Rhonda Patrick· PhD
The release of IL-6, conventionally thought a simple marker of inflammation, actually plays a crucial role in the insulin sensitizing effects of exercise.
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
The release of IL-6, conventionally thought a simple marker of inflammation, actually plays a crucial role in the insulin sensitizing effects of exercise.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
We talk about the role of IL-6 as a myokine and necessary for the insulin-sensitizing effects of exercise.
So if you block IL-6 in a row that exercises, you block all the beneficial metabolic effects.
IL6, which we think of it as mostly inflammatory cytokine in the context of sickness, is a myokine in the context of exercise. We know in the context of exercise that IL6 plays a key role in exercise’s ability to induce insulin sensitivity.